Patents by Inventor Gerald P. Arne
Gerald P. Arne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8498698Abstract: The disclosure describes techniques of reducing or eliminating a commonality between two modules within the same implantable medical device. Each module within the implantable medical device provides therapy to a patient. The commonality between the two modules exists due to at least one common component shared by the two modules. The commonality between the two modules may create common-mode interference and a shunt current. In accordance with this disclosure, various isolation circuits located at various locations are disclosed to reduce or eliminate the commonality between the two modules. The reduction or elimination of the commonality between the two modules may reduce or eliminate common-mode interference and the shunt current.Type: GrantFiled: August 31, 2009Date of Patent: July 30, 2013Assignee: Medtronic, Inc.Inventors: William T. Donofrio, Paul G. Krause, James D. Reinke, David J. Peichel, Gerald P. Arne
-
Patent number: 8452394Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: GrantFiled: January 30, 2009Date of Patent: May 28, 2013Assignee: Medtronic, Inc.Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, James D. Reinke, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, Timothy Davis
-
Patent number: 8406893Abstract: A therapy or monitoring system may implement one or more techniques to mitigate interference between operation of a charging device that charges a first implantable medical device (IMD) implanted in a patient and a second IMD implanted in the patient. In some examples, the techniques may include modifying an operating parameter of the charging device in response to receiving an indication that a second IMD is implanted in the patient. The techniques also may include modifying an operating parameter of the second IMD in response to detecting the presence or operation of the charging device.Type: GrantFiled: October 30, 2009Date of Patent: March 26, 2013Assignee: Medtronic, Inc.Inventors: Paul G. Krause, William T. Donofrio, Gerald P. Arne, James D. Reinke, David J. Peichel, Timothy Davis, John E. Burnes
-
Patent number: 8301263Abstract: A first implantable medical device (IMD) implanted within a patient may communicate with a second IMD implanted within the patient by encoding information in an electrical stimulation signal. The delivery of the electrical stimulation signal may provide therapeutic benefits to the patient. The second IMD may sense the electrical stimulation signal, which may be presented as an artifact in a sensed cardiac signal, and process the sensed signal to retrieve the encoded information. The second IMD may modify its operation based on the received therapy information. Crosstalk between the first and second IMDs may be reduced using various techniques described herein. For example, the first IMD may generate the electrical stimulation signal to include a spread spectrum energy distribution or a predetermined signal signature. The second IMD may effectively remove a least some of the signal artifact in a sensed cardiac signal based on the predetermined signal signature.Type: GrantFiled: January 30, 2009Date of Patent: October 30, 2012Assignee: Medtronic, Inc.Inventors: William T. Donofrio, Paul G. Krause, Gerald P. Arne, John E. Burnes, David J. Peichel, Xiaohong Zhou
-
Patent number: 8265771Abstract: A therapy or monitoring system may implement one or more techniques to mitigate interference between operation of a charging device that charges a first implantable medical device (IMD) implanted in a patient and a second IMD implanted in the patient. In some examples, the techniques may include modifying an operating parameter of the charging device in response to receiving an indication that a second IMD is implanted in the patient. The techniques also may include modifying an operating parameter of the second IMD in response to detecting the presence or operation of the charging device.Type: GrantFiled: October 30, 2009Date of Patent: September 11, 2012Assignee: Medtronic, Inc.Inventors: William T. Donofrio, Paul Gordon Krause, Gerald P. Arne, James D. Reinke, David Jerome Peichel, Timothy Davis, John E. Burnes
-
Patent number: 8260412Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: GrantFiled: January 30, 2009Date of Patent: September 4, 2012Assignee: Medtronic, Inc.Inventors: Paul G. Krause, John E. Burnes, William T. Donofrio, David J. Peichel, Gerald P. Arne, Xiaohong Zhou, James D. Reinke, Timothy Davis
-
Patent number: 8249708Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: GrantFiled: January 30, 2009Date of Patent: August 21, 2012Assignee: Medtronic, Inc.Inventors: Paul G. Krause, John E. Burnes, William T. Donofrio, David J. Peichel, Gerald P. Arne, Xiaohong Zhou, James D. Reinke
-
Patent number: 8005539Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: GrantFiled: January 30, 2009Date of Patent: August 23, 2011Assignee: Medtronic, Inc.Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke, Timothy Davis
-
Publication number: 20100114197Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke, Timothy Davis
-
Publication number: 20100114211Abstract: Techniques for minimizing interference between the first and second medical devices or between the different therapy modules of a common medical device are described herein. In some examples, a medical device may include shunt-current mitigation circuitry and/or at least one clamping structure that helps minimize or even eliminate shunt-current that feeds into a first therapy module of the medical device via one or more electrodes electrically connected to the first therapy module. The shunt-current may be generated by the delivery of electrical stimulation by a second therapy module. The second therapy module may be enclosed in a common housing with the first therapy module or may be separate, e.g., a part of a separate medical device.Type: ApplicationFiled: August 31, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Gerald P. Arne, Xiaohong Zhou
-
Publication number: 20100114241Abstract: A therapy or monitoring system may implement one or more techniques to mitigate interference between operation of a charging device that charges a first implantable medical device (IMD) implanted in a patient and a second IMD implanted in the patient. In some examples, the techniques may include modifying an operating parameter of the charging device in response to receiving an indication that a second IMD is implanted in the patient. The techniques also may include modifying an operating parameter of the second IMD in response to detecting the presence or operation of the charging device.Type: ApplicationFiled: October 30, 2009Publication date: May 6, 2010Inventors: William T. Donofrio, Paul Gordon Krause, Gerald P. Arne, James D. Reinke, David Jerome Peichel, Timothy Davis, John E. Burnes
-
Publication number: 20100114189Abstract: A first implantable medical device (IMD) implanted within a patient may communicate with a second IMD implanted within the patient by encoding information in an electrical stimulation signal. The delivery of the electrical stimulation signal may provide therapeutic benefits to the patient. The second IMD may sense the electrical stimulation signal, which may be presented as an artifact in a sensed cardiac signal, and process the sensed signal to retrieve the encoded information. The second IMD may modify its operation based on the received therapy information. Crosstalk between the first and second IMDs may be reduced using various techniques described herein. For example, the first IMD may generate the electrical stimulation signal to include a spread spectrum energy distribution or a predetermined signal signature. The second IMD may effectively remove a least some of the signal artifact in a sensed cardiac signal based on the predetermined signal signature.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: William T. Donofrio, Paul G. Krause, Gerald P. Arne, John E. Burnes, David J. Peichel, Xiaohong Zhou
-
Publication number: 20100114203Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke
-
Publication number: 20100114198Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke
-
Publication number: 20100114208Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke, Timothy Davis
-
Publication number: 20100114216Abstract: A therapy or monitoring system may implement one or more techniques to mitigate interference between operation of a charging device that charges a first implantable medical device (IMD) implanted in a patient and a second IMD implanted in the patient. In some examples, the techniques may include modifying an operating parameter of the charging device in response to receiving an indication that a second IMD is implanted in the patient. The techniques also may include modifying an operating parameter of the second IMD in response to detecting the presence or operation of the charging device.Type: ApplicationFiled: October 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: Paul G. Krause, William T. Donofrio, Gerald P. Arne, James D. Reinke, David J. Peichel, Timothy Davis, John E. Burnes
-
Publication number: 20100114224Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Inventors: Paul G. Krause, John E. Burnes, William T. Donofrio, David J. Peichel, Gerald P. Arne, Xiaohong Zhou, James D. Reinke
-
Publication number: 20100114200Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Inventors: Paul G. Krause, John E. Burnes, William T. Donofrio, David J. Peichel, Gerald P. Arne, Xiaohong Zhou, James D. Reinke
-
Publication number: 20100114196Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, James D. Reinke, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, Timothy Davis
-
Publication number: 20100114202Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke